I uge 52 havde 89% af de patienter, der var genrandomiseret til vedligeholdelsesbehandling, PASI 75- respons sammenholdt med 63% af de patienter, der var genrandomiseret til placebo (behandlingsophør) (p < 0, 001).
At Week 52, 89% of patients re-randomised to maintenance treatment were PASI 75 responders compared with 63% of patients re-randomised to placebo (treatment withdrawal) (p < 0.001).